Atacama Therapeutics focuses on developing treatments for hyperhidrosis.
Atacama Therapeutics has raised $830K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.
Atacama Therapeutics is headquartered in Wellesley, United States.
Atacama Therapeutics focuses on developing treatments for hyperhidrosis.
Atacama Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Atacama Therapeutics — Funding & Investors." VCBacked, May 6, 2024, https://www.vcbacked.co/company/atacama-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). Atacama Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/atacama-therapeutics
{{cite web |title=Atacama Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/atacama-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated